Costa, C <br/><br/>
Value of NMO-IgG determination at the time of presentation as CIS.  [electronic resource] 

 -  Neurology  May 2012 
 - 1608-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/WNL.0b013e3182563b32  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aquaporin 4--immunology<br/>Cohort Studies<br/>Demyelinating Diseases--physiopathology<br/>Female<br/>Humans<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Neuromyelitis Optica--blood<br/>Oligoclonal Bands--blood<br/>Retrospective Studies<br/>Time Factors<br/>White People<br/>Young Adult